Gen9 Garners $25,000,000 New Financing Round

  • Feed Type
  • Date
    7/30/2014
  • Company Name
    Gen9
  • Mailing Address
    840 Memorial Drive 5th Floor Cambridge, MA 01239 USA
  • Company Description
    Synthetic Biology is poised to modernize trillion dollar industries by introducing genes that program microorganisms to produce pharmaceuticals, biofuels and chemicals. A small number of Gen9’s current production tools generate sufficient DNA content to, in principle, replace the world’s current annual output of synthetic genes.
  • Website
    http://www.gen9bio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy